Given the putative anti-inflammatory role of IL-10, the finding of a higher proportion of A carriers (presumed to be a low IL-10 producer) in a subgroup of CIDP patients with low INCAT is somewhat unexpected. This evidence concerns the gene IL10 and chronic inflammatory demyelinating polyradiculoneuropathy.